Jocasta Neuroscience Secures $35 Million Series A Funding for Cognitive Health Innovations Jocasta Neuroscience has successfully raised $35 million in Series A funding, aiming to develop a-groundbreaking protein therapy to combat cognitive decline in neurodegenerative diseases.

Jocasta Neuroscience Secures $35 Million Series A Funding for Cognitive Health Innovations #United_States #Scottsdale,_Arizona #Cognitive_Decline #Jocasta_Neuroscience #a-Klotho